BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19495755)

  • 1. Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call(®)) in patients with unresectable hepatocellular carcinoma.
    Yamashita Y; Taketomi A; Itoh S; Harimoto N; Morita K; Fukuhara T; Ueda S; Sanefuji K; Sugimachi K; Tajima T; Maehara Y
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):301-7. PubMed ID: 19495755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DDP-H, new formulation of cisplatin for hepatic artery infusion therapy].
    Furue H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():670-3. PubMed ID: 11762034
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of advanced hepatocellular carcinoma effectively treated with 5-fluorouracil and high-concentration cisplatin suspended in lipiodol by short-term hepatic arterial infusion chemotherapy].
    Yata Y; Kanda D; Takeuchi S; Hatanaka T; Iesaki K; Yoshinaga T; Kubota J; Higuchi T
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1179-81. PubMed ID: 19620813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.
    Koizumi Y; Hirooka M; Uehara T; Kisaka Y; Uesugi K; Kumagi T; Abe M; Matsuura B; Hiasa Y; Onji M
    Hepatogastroenterology; 2011; 58(106):512-5. PubMed ID: 21661422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma.
    Kanematsu T; Matsumata T; Furuta T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):442-4. PubMed ID: 2174820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy with Cisplatin-Phosphatidyl-choline-Lipiodol (CPL) suspension in unresectable hepatocellular carcinoma].
    Aoki Y; Hirai K; Yamashita K; Noguchi H; Sakai T; Majima Y; Tanikawa K; Inoue H; Okano Y; Hitoshi T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3066-9. PubMed ID: 2476969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of concentrated CDDP-lipiodol emulsion for hepatic arterial infusion therapy in patients with nonresectable hepatoma].
    Nakashima K; Iwao Y; Suzuki K; Tada I; Kim YI; Kobayashi M; Mori K; Takayama F; Takeyama M; Aikawa H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1731-5. PubMed ID: 2167645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma.
    Kamimura K; Suda T; Tamura Y; Takamura M; Yokoo T; Igarashi M; Kawai H; Yamagiwa S; Nomoto M; Aoyagi Y
    BMC Gastroenterol; 2012 Sep; 12():127. PubMed ID: 22994941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
    Tarusawa K; Yodono H; Ikami I; Sasaki T; Kanehira J; Takahashi S; Shibutani K; Noda H; Shinohara A; Takekawa D
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):383-6. PubMed ID: 1311915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
    Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
    Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin).
    Watanabe S; Nitta N; Ohta S; Sonoda A; Otani H; Tomozawa Y; Nitta-Seko A; Tsuchiya K; Tanka T; Takahashi M; Murata K
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):399-405. PubMed ID: 21584842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma].
    Usui T; Shiozawa S; Kim DH; Tsuchiya A; Masuda T; Inose S; Aizawa M; Yoshimatsu K; Katsube T; Naritaka Y; Ogawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2702-4. PubMed ID: 21224685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma.
    Yodono H; Matsuo K; Shinohara A
    Anticancer Drugs; 2011 Mar; 22(3):277-82. PubMed ID: 21360850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of successful treatment with intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombus].
    Mukai Y; Takeda Y; Nakahira S; Kawashima H; Hamanaka M; Uchiyama C; Kanemura T; Takeno A; Okishiro M; Suzuki R; Egawa C; Taniguchi H; Nakata K; Miki H; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1815-8. PubMed ID: 23267896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intra-arterial infusion chemotherapy of cisplatin (CDDP)-lipiodol suspension using implantable injection port for unresectable liver cancer patients].
    Aogi K; Sawamura A; Funakoshi M; Toge T
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1485-8. PubMed ID: 7690535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive high-dose intra-hepatic artery chemotherapy for unresectable hepatocellular carcinoma (HCC).
    Carr BI
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1379. PubMed ID: 8854757
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.